Clinical Trial Update: Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of liposome-encapsulated cyclosporine A for bronchiolitis obliterans after double-lung transplantation has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Lung Allograft Dysfunction
• Lung Transplant Rejection
• Rejection of Lung Transplant

Drugs mentioned

• Liposomal cyclosporine A (cyclosporine A liposome formulation)

Snippet

Sponsor: Zambon SpA | Conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant | Phase 3 | Status: COMPLETED | Results posted: 2025-07-24